Close Menu

University of California, Berkeley, researcher and CRISPR pioneer Jennifer Doudna reviews the scientific, technical, and ethical aspects of using the genome editing technology for therapeutic applications in this week's Nature. In her review, she presents examples highlighting both the potential and pitfalls of these efforts, and calls for "active efforts to ensure that this breakthrough technology is used responsibly to treat, cure, and prevent genetic disease."

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A federal judge has ruled that drug companies, device manufacturers, and universities need to provide missing clinical data from hundreds of trials to a federal website, ScienceInsider reports.

A genetic analysis suggests red pandas might actually belong to two different species, New Scientist reports.

NPR reports that the US Centers for Disease Control and Prevention has fixed the problem with some of its SARS-CoV-2 testing kits.

In Nature this week: epigenetic factors that prevent healthy aging and more.